Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Aurora Cannabis Inc (ACB) vs Expensify Inc (EXFY) Price & Performance

Aurora Cannabis IncTrade
Expensify IncTrade

Price performance (Past 24H)

Key statistics

Aurora Cannabis Inc vs Expensify Inc — how do they compare? Aurora Cannabis Inc trades at $3.79 (market cap $223.59M), while Expensify Inc trades at $2.27 (market cap $209.73M). The key difference: Aurora Cannabis Inc and Expensify Inc are close in size by market cap, and Expensify Inc is trading nearer its 52-week high, Aurora Cannabis Inc nearer its low. Which is the better fit depends on your goals.

ACBEXFY
Market Cap
$223.59M$209.73M
Sector
HealthTechnology
52-Week High
$6.23$2.69
52-Week Low
$2.58$0.75
Enterprise Value
$168.09M$149.35M

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Aurora Cannabis Inc

Aurora Cannabis (ACB) trades at $3.82, up 32.18% amid Curaleaf's hostile takeover bid offering a 45% premium. The stock shows mixed technical signals with neutral RSI but bearish moving averages. Fundamentally, ACB achieved profitability in 2025 with $1.59M net income after years of losses, though 2026 projections show renewed negative margins. Revenue grew 27% year-over-year to $343M, but the company faces significant execution risks in a competitive cannabis market.

The takeover bid creates near-term upside potential to $4 per share, but standalone prospects remain challenged by negative profitability projections and competitive pressures. Investors face a binary outcome: accept the premium offer or risk ACB's volatile standalone execution amid declining 2026 revenue and negative margins.

Expensify Inc

Expensify (EXFY) trades at $2.22, down 10.12% in the past 24 hours, with a bullish technical signal from moving averages and a neutral RSI. Recent Q2 2026 earnings showed a beat on EPS and a return to non-GAAP profitability, with revenue of $33.9 million. The company is expanding its AI-native solutions and European card offerings, supported by positive cash flow trends.

Outlook is cautiously optimistic due to earnings improvements and strategic expansions, but risks include persistent net losses, high P/E ratio of 258.82, and competitive pressures in expense management software. Analyst consensus is mixed with 44% buy ratings.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Aurora Cannabis Inc

Aurora Cannabis, based in Edmonton, Canada, grows and distributes both medical and recreational cannabis under several brands, including Drift, San Rafael '71, Daily Special, Whistler, Being, and Greybeard. While its main market is Canada, the company has also expanded globally through medical cannabis export agreements.

Read more on ACB

About Expensify Inc

Expensify Inc is a cloud-based expense management software platform that helps the smallest to the largest businesses simplify the way they manage money. More than 10 million people use Expensify's free features, which include corporate cards, expense tracking, next-day reimbursement, invoicing, bill pay, and travel booking in one app.

Read more on EXFY